Details for New Drug Application (NDA): 209217
✉ Email this page to a colleague
The generic ingredient in CEFAZOLIN SODIUM is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
Summary for 209217
Tradename: | CEFAZOLIN SODIUM |
Applicant: | Qilu |
Ingredient: | cefazolin sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 209217
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 209217 | ANDA | Apotex Corp. | 60505-6143 | 60505-6143-4 | 10 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (60505-6143-4) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PHARMACY BULK PACKAGE (60505-6143-0) |
CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 209217 | ANDA | Apotex Corp. | 60505-6244 | 60505-6244-4 | 10 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (60505-6244-4) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PHARMACY BULK PACKAGE (60505-6244-0) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10GM BASE/VIAL | ||||
Approval Date: | Oct 17, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription